SNC THERAPEUTICS, INC. — Department of the Interior STTR Phase II: ARPA-H SNC QUIET
SNC THERAPEUTICS, INC. — STTR Phase II award from Department of the Interior.
Phase II STTR prototype / development signal
- Phase II is where Department of the Interior funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $3,499,423, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
SNC Therapeutics, Inc. received a $3.5 million STTR Phase II award to support ARPA-H's QUIET project. The funding helps develop advanced therapeutic technologies for health applications.
- Amount
- $3,499,423
- Agency
- Department of the Interior · Departmental Offices
- Program / Phase
- STTR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- IL
- Period
- 2026-09-24 → 2028-09-27
Technology domains
Description
ARPA-H SNC QUIET STTR PHASE II